Applied Therapeutics Inc. (APLT)
NASDAQ: APLT
· Real-Time Price · USD
0.48
-0.03 (-5.70%)
At close: Jul 25, 2025, 3:59 PM
Applied Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -43.51M | -105.62M | -187.31M | -161.09M | -193.56M | -119.76M | -96.51M | -73.24M | -69.52M | -82.51M | -95.24M | -104.56M | -104.53M | -105.58M | -102.11M | -103.54M | -105.77M |
Depreciation & Amortization | 631K | 646K | 572K | 365K | 359K | 354K | 462K | 456K | 449K | 443K | 436K | 428K | 423K | 415K | 407K | 398K | 387K |
Stock-Based Compensation | 12.57M | 13.47M | 7.99M | 7.73M | 7.68M | 7.36M | 7.73M | 8.75M | 9.14M | 9.16M | 10.01M | 9.8M | 10.27M | 11.18M | 10.88M | 10.64M | 9.68M |
Other Working Capital | 4.46M | 2.79M | 4.87M | -4.1M | -90K | 1.35M | -2.17M | -1.17M | -3.87M | -3.92M | -9.29M | -2.87M | -580K | -5.15M | -5.09M | 994K | 8.98M |
Other Non-Cash Items | -60.23M | 5.53M | 140.82M | 103.81M | 123.89M | 58.32M | -4.41M | -3.66M | 3.5M | 3.65M | 7.14M | 6.4M | 28K | -404K | -396K | -385K | -370K |
Deferred Income Tax | n/a | n/a | -41.8M | -14.14M | n/a | n/a | 41.8M | 14.14M | n/a | n/a | n/a | n/a | -990K | n/a | 2.55M | 2.55M | 3.54M |
Change in Working Capital | 6.62M | 5.49M | 1.7M | -6.1M | -3.38M | -1.44M | -3.13M | -5.17M | -4.24M | -8.84M | -11.49M | 2.51M | 1.87M | 3.67M | 2.13M | -1.23M | 10.97M |
Operating Cash Flow | -94.03M | -84.31M | -81.84M | -73.24M | -67.09M | -55.17M | -54.06M | -58.73M | -60.67M | -78.09M | -89.14M | -85.42M | -92.92M | -90.73M | -86.54M | -91.56M | -81.57M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -27.31M | -49.23M | -58.22M | -64.22M | -49.38M | -42.03M | -39.58M | -121.59M | -116.22M | -211.54M | -180.96M |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | 13.87M | 34.27M | 61.22M | 75.74M | 77.39M | 81.26M | 77.41M | 86.21M | 134.02M | 145.29M | 184.74M | 161.42M |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | -6.91M | -1.88M | 3.65M | 13.17M | 31.88M | 35.38M | 46.63M | 12.43M | 29.07M | 37.66M | 44.92M |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 13.87M | 6.97M | 11.99M | 17.52M | 13.17M | 31.88M | 35.38M | 46.63M | 12.43M | 29.07M | -9.69M | -2.43M |
Debt Repayment | n/a | -311K | -776K | -1.24M | -1.55M | -1.86M | -2.33M | -2.79M | -3.11M | -3.27M | -3.52M | -3.78M | -4.43M | -4.72M | -1.39M | -1.28M | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -1.69M | n/a | n/a | n/a | -39K | -39K | -39K | -39K | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 310K | 9.37M | 9.37M | 19.69M | 20.94M | 11.89M | 11.88M | 1.62M | 3.15M | 3.15M | 3.15M | 3.21M | 4.88M | 5.01M | 5.96M | 5.16M | 612K |
Financial Cash Flow | -1.69M | 113.81M | 143.25M | 159.82M | 190.66M | 74.54M | 44.16M | 26.63M | 27.86M | 27.69M | 27.44M | 27.33M | 442K | 74.72M | 78.99M | 78.84M | 75.56M |
Net Cash Flow | -95.72M | 41.94M | 73.85M | 99.02M | 136.01M | 33.24M | -2.93M | -20.11M | -15.3M | -37.23M | -29.82M | -22.71M | -45.85M | -3.58M | 21.53M | -22.42M | -8.44M |
Free Cash Flow | -94.03M | -84.31M | -81.84M | -73.24M | -67.09M | -55.17M | -54.06M | -58.73M | -60.67M | -78.09M | -89.14M | -85.42M | -92.92M | -90.73M | -86.54M | -91.56M | -81.57M |